GE HealthCare Technologies Inc. (GEHC) Financials
Annual revenue, profitability and per-share results for GE HealthCare Technologies Inc., as reported in SEC filings.
Revenue • FY2025
$20.63B
▲ 4.8%YoY
Net income • FY2025
$2.08B
▲ 4.6%YoY
Gross margin • FY2025
40.0%
Diluted EPS • FY2025
$4.55
▲ 4.8%YoY
Annual income statement
| Period | Revenue | Net income | Gross profit | Dil. EPS | Free cash flow | Op. margin | Rev. growth |
|---|---|---|---|---|---|---|---|
| FY2025 | $20.63B | $2.08B | $8.25B | $4.55 | $1.5B | 13.4% | +4.8% |
| FY2024 | $19.67B | $1.99B | $8.21B | $4.34 | $1.55B | 13.3% | +0.6% |
| FY2023 | $19.55B | $1.57B | $7.92B | $3.03 | $1.71B | 12.4% | — |
| FY2022 | — | — | — | — | — | — | — |
Figures as reported in GE HealthCare Technologies Inc.'s 10-K filings on SEC EDGAR. Fiscal years may differ from calendar years.
Never miss a GEHC filing.
Get an email when GEHC files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR.